沙雷肽酶 Serrapeptase × 運動恢復/術後消腫

結論:證據分歧

Examine assigns a B grade to Surgical Recovery - Inflammation (3 studies, 390 participants), but an independent reading of the underlying evidence shows this overstates the case.

C 🟠 C 薄弱證據 證據分歧 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 🇹🇼 台灣在地警示

Examine assigns a B grade to Surgical Recovery - Inflammation (3 studies, 390 participants), but an independent reading of the underlying evidence shows this overstates the case. The supporting trials are almost entirely post-dental-extraction studies (impacted third molar surgery), not exercise recovery, which is a genuine scope mismatch with the engine's COND-recovery target; they are old, small, and consistently graded low quality under RoB 2.0/GRADE. Critically, a 2023 GRADE-rated meta-analysis found that serrapeptase reduces trismus but does NOT reduce inflammation/swelling or pain, and head-to-head trials show dexamethasone reduces swelling better than serrapeptase. The largest positive RCT (n=133) was industry-funded, and the prescription version (Danzen/Dasen) was withdrawn by Takeda in Japan in 2011 after post-marketing double-blind trials failed to beat placebo. Mayo, Cleveland Clinic, Harvard, ACSM and ISSN all have no position on serrapeptase for recovery. Weighing the inconsistent outcomes, low trial quality, regulatory withdrawal, and total absence of any exercise-recovery evidence, a C grade (preliminary, contested) is more honest than Examine's B.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.47
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 證據分歧
信心度
71%
證據方向大致一致
證據層級
E2
多篇高品質統合分析(≥2 篇一致)

各層「支持此療效」的程度

分數越低=該層越不支持
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L5 臨床機構權威立場
0.50
L11 AI 複核獨立判讀
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.472
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Role of Serratiopeptidase After Surgical Removal of Impacted Molar: A Systematic Review and Meta-analysis
PMID: 29618875 2018 統合分析 n = 5
結論:Serratiopeptidase improved trismus better than corticosteroids on days 1/3/5/7 (MD 4.42, 95% CI 3.84 to 5.00); corticosteroids reduced swelling better than serratiopeptidase on day 1 (MD 2.95, 95% CI 0.83 to 5.07) with no significant difference thereafter; pain meta-analysis could not be completed due to heterogeneous reporting. Authors concluded serratiopeptidase could be used safely and effectively for trismus and swelling.
🟠 品質有限 效應量:Trismus MD 4.42 mm vs corticosteroids; swelling favored corticosteroids day 1 only (MD 2.95)
前往 PubMed
Efficacy of serratiopeptidase after impacted third molar surgery: a randomized controlled clinical trial
PMID: 33653320 2021 RCT (double-blind) n = 133
結論:Treatment group showed significantly better trismus by day 4 (27.30 ± 7.3 mm vs 32.06 ± 7.7 mm, P<0.001) and less swelling (earlobe-to-symphysis 111.49 ± 8.1 mm vs 115.39 ± 9.9 mm, P<0.001); pain showed no statistically significant difference between groups.
⚠️ 廠商資助 效應量:Trismus and swelling significant favoring serratiopeptidase; pain NS
前往 PubMed
Comparison of the roles of serratiopeptidase and dexamethasone in the control of inflammation and trismus following impacted third molar surgery
PMID: 23649050 2013 隨機對照試驗 n = 110
結論:Dexamethasone was more effective than serratiopeptidase for reducing swelling and pain; both agents had equivalent effect on trismus.
🟠 品質有限 效應量:Dexamethasone superior for swelling/pain; equivalent for trismus
前往 PubMed
Efficacy of serratiopeptidase in third molar surgery. A systematic review and meta-analysis
PMID: 2023 統合分析 n = 6
— 詳細結論請見 PubMed 原文
前往 PubMed

L4a US FDA
謹慎
Products may be legally marketed as dietary supplements if claims about diagnosis, cure, mitigation, treatment, or prevention are removed from promotional materials and the products otherwise comply with all applicable provisions of the Act and FDA regulations. 來源↗
L4b EU EFSA
反對
L4c UK NHS
反對
Serratiopeptidase is an unauthorised novel food, and it is illegal for businesses to sell serrapeptase as a food supplement for human consumption in the EU and UK because it is an unauthorised novel food. 來源↗
L4d TW TFDA / 衛福部
中性
適應症:手術後及外傷後之消炎、副鼻腔炎、膀胱炎、副睪丸炎、智齒周圍炎、齒槽膿瘍之消炎、支氣管炎。 來源↗
L4e WHO
未表態
— 本適應症無對應資料

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
未表態
— 本適應症無對應資料
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態
— 本適應症無對應資料

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

針對「沙雷肽酶(serrapeptase)× 運動恢復/術後消腫」這個特定組合,PTT(MuscleBeach/FITNESS/teeth_salon/regimen)、Dcard、Mobile01 幾乎沒有任何鄉民實測心得。台灣社群在『拔智齒/開刀/運動傷害後消腫』的討論幾乎被冰敷、消炎止痛藥(如百炎淨、ponstan)、膠原蛋白、休息與抬高所佔據,沒有人把沙雷肽酶當成消腫補充品在分享。少數出現『沙雷肽酶/舍雷肽酶』的繁中頁面幾乎都是電商與賣家部落格(盈康社 Yield Healthy Life 商品頁與 Xuite 部落格、iHerb 業配導購、formulawave/亞尼活力等 affiliate 科普文),以及藥品查詢站(KingNet)與中國醫療百科(百度百科、唤醒食物),而非台灣論壇的真實使用回報。屬於『該保健品在此適應症下台灣社群討論極度稀薄、僅見商品頁與業配科普』的稀疏結果,不足以作為在地使用經驗證據。

💬社群實感

無共識(針對運動恢復/術後消腫此適應症,台灣 PTT/Dcard/Mobile01 幾乎查無沙雷肽酶的實測心得;術後消腫討論集中在冰敷、消炎止痛藥、膠原蛋白與休息)

破解迷思 社群最常見的 3 個誤解
事實把賣家部落格與 iHerb/affiliate 科普文引述的『沙雷肽酶可分解纖維蛋白、明顯加速術後與運動傷害消腫』當成台灣鄉民實證共識(實為廠商導購與國外少量舊研究,非社群實測)
事實誤以為沙雷肽酶是主流的運動恢復/術後消腫保健品(台灣社群此用途首選仍是冰敷、消炎藥、膠原蛋白,沙雷肽酶幾乎不被提及)
事實忽略沙雷肽酶具抗凝血傾向,與 warfarin/阿斯匹靈/抗血小板藥併用可能增加出血風險,術後階段尤其需留意(賣場頁多淡化此警示)

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

強效沙雷肽酶Serrapeptase(延遲釋放)

代表來源 ↗
L10b · TFDA 法定身份 官方認定

以現在要求的臨床數據評估,並無足夠證據足以支持其療效

來源 ↗

  • 充足睡眠與睡眠延長
  • 主動恢復與訓練負荷管理
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v22 engine_version: v1.0 claim_id: CLM-COND-recovery-INT-serrapeptase-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-recovery-INT-serrapeptase-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "沙雷肽酶能改善運動恢復/術後消腫",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}